APO Research

APO RESEARCH · REPORT

Alternative Medicines and Therapy

Selected research

Market Analysis & Forecast

Global Alternative Medicines and Therapy Market Analysis and Forecast 2026-2032

Market perspective

The global Alternative Medicines and Therapy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Alternative Medicines and Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Alternative Medicines and Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Alternative Medicines and Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Alternative Medicines and Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Alternative Medicines and Therapy include Allen Laboratories Ltd., Arya Vaidya Pharmacy, Dr. Reddy’s Laboratories Ltd, King Bio Pharmaceuticals, Mediral International, Sandoz International GmbH, Biocon Ltd., Sante Verte Ltd., Weleda Ltd., Cipla Ltd. and Wright Health Group Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Alternative Medicines and Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Alternative Medicines and Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Alternative Medicines and Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alternative Medicines and Therapy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Alternative Medicines and Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Alternative Medicines and Therapy revenue, projected growth trends, production technology, application and end-user industry.

Alternative Medicines and Therapy Segment by Company

Allen Laboratories Ltd.

Arya Vaidya Pharmacy

Dr. Reddy’s Laboratories Ltd

King Bio Pharmaceuticals

Mediral International

Sandoz International GmbH, Biocon Ltd.

Sante Verte Ltd.

Weleda Ltd., Cipla Ltd.

Wright Health Group Ltd.

Alternative Medicines and Therapy Segment by Type

Oil Massage Therapy

Mud Therapy

Magnetic Therapy

Alternative Medicines and Therapy Segment by Application

Hospital

Clinic

Alternative Medicines and Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alternative Medicines and Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alternative Medicines and Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alternative Medicines and Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Alternative Medicines and Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Alternative Medicines and Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alternative Medicines and Therapy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Alternative Medicines and Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oil Massage Therapy Major Player Table 3. Mud Therapy Major Player Table 4. Magnetic Therapy Major Player Table 5. Global Alternative Medicines and Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Clinic Major Player Table 8. Alternative Medicines and Therapy Industry Trends Table 9. Alternative Medicines and Therapy Industry Drivers Table 10. Alternative Medicines and Therapy Industry Opportunities and Challenges Table 11. Alternative Medicines and Therapy Industry Restraints Table 12. Global Alternative Medicines and Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Alternative Medicines and Therapy Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Alternative Medicines and Therapy Market Share by Region (2021-2026) Table 15. Global Alternative Medicines and Therapy Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Alternative Medicines and Therapy Market Share by Region (2027-2032) Table 17. Global Alternative Medicines and Therapy Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Alternative Medicines and Therapy Revenue Market Share by Players (2021-2026) Table 19. Global Alternative Medicines and Therapy Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Alternative Medicines and Therapy Key Players Headquarters & Area Served Table 21. Global Alternative Medicines and Therapy Players, Product Type & Application Table 22. Global Alternative Medicines and Therapy Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Alternative Medicines and Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Alternative Medicines and Therapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Alternative Medicines and Therapy Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Alternative Medicines and Therapy Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Alternative Medicines and Therapy Revenue Market Share by Type (2021-2026) Table 29. Global Alternative Medicines and Therapy Revenue Market Share by Type (2027-2032) Table 30. Global Alternative Medicines and Therapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Alternative Medicines and Therapy Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Alternative Medicines and Therapy Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Alternative Medicines and Therapy Revenue Market Share by Application (2021-2026) Table 34. Global Alternative Medicines and Therapy Revenue Market Share by Application (2027-2032) Table 35. Allen Laboratories Ltd. Company Information Table 36. Allen Laboratories Ltd. Business Overview Table 37. Allen Laboratories Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Allen Laboratories Ltd. Alternative Medicines and Therapy Product Portfolio Table 39. Allen Laboratories Ltd. Recent Development Table 40. Arya Vaidya Pharmacy Company Information Table 41. Arya Vaidya Pharmacy Business Overview Table 42. Arya Vaidya Pharmacy Alternative Medicines and Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Arya Vaidya Pharmacy Alternative Medicines and Therapy Product Portfolio Table 44. Arya Vaidya Pharmacy Recent Development Table 45. Dr. Reddy’s Laboratories Ltd Company Information Table 46. Dr. Reddy’s Laboratories Ltd Business Overview Table 47. Dr. Reddy’s Laboratories Ltd Alternative Medicines and Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Dr. Reddy’s Laboratories Ltd Alternative Medicines and Therapy Product Portfolio Table 49. Dr. Reddy’s Laboratories Ltd Recent Development Table 50. King Bio Pharmaceuticals Company Information Table 51. King Bio Pharmaceuticals Business Overview Table 52. King Bio Pharmaceuticals Alternative Medicines and Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. King Bio Pharmaceuticals Alternative Medicines and Therapy Product Portfolio Table 54. King Bio Pharmaceuticals Recent Development Table 55. Mediral International Company Information Table 56. Mediral International Business Overview Table 57. Mediral International Alternative Medicines and Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Mediral International Alternative Medicines and Therapy Product Portfolio Table 59. Mediral International Recent Development Table 60. Sandoz International GmbH, Biocon Ltd. Company Information Table 61. Sandoz International GmbH, Biocon Ltd. Business Overview Table 62. Sandoz International GmbH, Biocon Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sandoz International GmbH, Biocon Ltd. Alternative Medicines and Therapy Product Portfolio Table 64. Sandoz International GmbH, Biocon Ltd. Recent Development Table 65. Sante Verte Ltd. Company Information Table 66. Sante Verte Ltd. Business Overview Table 67. Sante Verte Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sante Verte Ltd. Alternative Medicines and Therapy Product Portfolio Table 69. Sante Verte Ltd. Recent Development Table 70. Weleda Ltd., Cipla Ltd. Company Information Table 71. Weleda Ltd., Cipla Ltd. Business Overview Table 72. Weleda Ltd., Cipla Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Weleda Ltd., Cipla Ltd. Alternative Medicines and Therapy Product Portfolio Table 74. Weleda Ltd., Cipla Ltd. Recent Development Table 75. Wright Health Group Ltd. Company Information Table 76. Wright Health Group Ltd. Business Overview Table 77. Wright Health Group Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Wright Health Group Ltd. Alternative Medicines and Therapy Product Portfolio Table 79. Wright Health Group Ltd. Recent Development Table 80. North America Alternative Medicines and Therapy Revenue by Type (2021-2026) & (US$ Million) Table 81. North America Alternative Medicines and Therapy Revenue by Type (2027-2032) & (US$ Million) Table 82. North America Alternative Medicines and Therapy Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Alternative Medicines and Therapy Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Alternative Medicines and Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Alternative Medicines and Therapy Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Alternative Medicines and Therapy Revenue by Country (US$ Million) & (2027-2032) Table 87. Europe Alternative Medicines and Therapy Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Alternative Medicines and Therapy Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Alternative Medicines and Therapy Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Alternative Medicines and Therapy Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Alternative Medicines and Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Alternative Medicines and Therapy Revenue by Country (2021-2026) & (US$ Million) Table 93. Europe Alternative Medicines and Therapy Revenue by Country (US$ Million) & (2027-2032) Table 94. China Alternative Medicines and Therapy Revenue by Type (2021-2026) & (US$ Million) Table 95. China Alternative Medicines and Therapy Revenue by Type (2027-2032) & (US$ Million) Table 96. China Alternative Medicines and Therapy Revenue by Application (2021-2026) & (US$ Million) Table 97. China Alternative Medicines and Therapy Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Alternative Medicines and Therapy Revenue by Type (2021-2026) & (US$ Million) Table 99. Asia Alternative Medicines and Therapy Revenue by Type (2027-2032) & (US$ Million) Table 100. Asia Alternative Medicines and Therapy Revenue by Application (2021-2026) & (US$ Million) Table 101. Asia Alternative Medicines and Therapy Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Alternative Medicines and Therapy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Alternative Medicines and Therapy Revenue by Region (US$ Million) & (2021-2026) Table 104. Asia Alternative Medicines and Therapy Revenue by Region (US$ Million) & (2027-2032) Table 105. SAMEA Alternative Medicines and Therapy Revenue by Type (2021-2026) & (US$ Million) Table 106. SAMEA Alternative Medicines and Therapy Revenue by Type (2027-2032) & (US$ Million) Table 107. SAMEA Alternative Medicines and Therapy Revenue by Application (2021-2026) & (US$ Million) Table 108. SAMEA Alternative Medicines and Therapy Revenue by Application (2027-2032) & (US$ Million) Table 109. SAMEA Alternative Medicines and Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. SAMEA Alternative Medicines and Therapy Revenue by Country (2021-2026) & (US$ Million) Table 111. SAMEA Alternative Medicines and Therapy Revenue by Country (US$ Million) & (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Alternative Medicines and Therapy Image Figure 2. Global Alternative Medicines and Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alternative Medicines and Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oil Massage Therapy Image Figure 5. Mud Therapy Image Figure 6. Magnetic Therapy Image Figure 7. Global Alternative Medicines and Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Alternative Medicines and Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Global Alternative Medicines and Therapy Market Size (US$ Million) & (2021-2032) Figure 12. Global Alternative Medicines and Therapy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Alternative Medicines and Therapy Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Alternative Medicines and Therapy Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Alternative Medicines and Therapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Alternative Medicines and Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Alternative Medicines and Therapy Revenue Market Share by Type (2021-2032) Figure 19. Global Alternative Medicines and Therapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Alternative Medicines and Therapy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Alternative Medicines and Therapy Revenue Market Share by Application (2021-2032) Figure 22. North America Alternative Medicines and Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Alternative Medicines and Therapy Revenue Share by Type (2021-2032) Figure 24. North America Alternative Medicines and Therapy Revenue Share by Application (2021-2032) Figure 25. North America Alternative Medicines and Therapy Revenue Share by Country (2021-2032) Figure 26. United States Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Alternative Medicines and Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Alternative Medicines and Therapy Revenue Share by Type (2021-2032) Figure 31. Europe Alternative Medicines and Therapy Revenue Share by Application (2021-2032) Figure 32. Europe Alternative Medicines and Therapy Revenue Share by Country (2021-2032) Figure 33. Germany Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Alternative Medicines and Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Alternative Medicines and Therapy Revenue Share by Type (2021-2032) Figure 43. China Alternative Medicines and Therapy Revenue Share by Application (2021-2032) Figure 44. Asia Alternative Medicines and Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Alternative Medicines and Therapy Revenue Share by Type (2021-2032) Figure 46. Asia Alternative Medicines and Therapy Revenue Share by Application (2021-2032) Figure 47. Asia Alternative Medicines and Therapy Revenue Share by Region (2021-2032) Figure 48. Japan Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Alternative Medicines and Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Alternative Medicines and Therapy Revenue Share by Type (2021-2032) Figure 56. SAMEA Alternative Medicines and Therapy Revenue Share by Application (2021-2032) Figure 57. SAMEA Alternative Medicines and Therapy Revenue Share by Country (2021-2032) Figure 58. Brazil Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Alternative Medicines and Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oil Massage Therapy
  • Mud Therapy
  • Magnetic Therapy
Applications
  • Hospital
  • Clinic
Companies covered
  • Allen Laboratories Ltd.
  • Arya Vaidya Pharmacy
  • Dr. Reddy’s Laboratories Ltd
  • King Bio Pharmaceuticals
  • Mediral International
  • Sandoz International GmbH, Biocon Ltd.
  • Sante Verte Ltd.
  • Weleda Ltd., Cipla Ltd.
  • Wright Health Group Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Alternative Medicines and Therapy Market by Type
  3. 1.2.1 Global Alternative Medicines and Therapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oil Massage Therapy
  5. 1.2.3 Mud Therapy
  6. 1.2.4 Magnetic Therapy
  7. 1.3 Alternative Medicines and Therapy Market by Application
  8. 1.3.1 Global Alternative Medicines and Therapy Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Alternative Medicines and Therapy Market Dynamics
  1. 2.1 Alternative Medicines and Therapy Industry Trends
  2. 2.2 Alternative Medicines and Therapy Industry Drivers
  3. 2.3 Alternative Medicines and Therapy Industry Opportunities and Challenges
  4. 2.4 Alternative Medicines and Therapy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Alternative Medicines and Therapy Market Perspective (2021-2032)
  2. 3.2 Global Alternative Medicines and Therapy Growth Trends by Region
  3. 3.2.1 Global Alternative Medicines and Therapy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Alternative Medicines and Therapy Market Size by Region (2021-2026)
  5. 3.2.3 Global Alternative Medicines and Therapy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Alternative Medicines and Therapy Revenue by Players
  2. 4.1.1 Global Alternative Medicines and Therapy Revenue by Players (2021-2026)
  3. 4.1.2 Global Alternative Medicines and Therapy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Alternative Medicines and Therapy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Alternative Medicines and Therapy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Alternative Medicines and Therapy Key Players Headquarters & Area Served
  7. 4.4 Global Alternative Medicines and Therapy Players, Product Type & Application
  8. 4.5 Global Alternative Medicines and Therapy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Alternative Medicines and Therapy Market CR5 and HHI
  11. 4.6.3 2025 Alternative Medicines and Therapy Tier 1, Tier 2, and Tier 3
5 Alternative Medicines and Therapy Market Size by Type
  1. 5.1 Global Alternative Medicines and Therapy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Alternative Medicines and Therapy Revenue by Type (2021-2032)
  3. 5.3 Global Alternative Medicines and Therapy Revenue Market Share by Type (2021-2032)
6 Alternative Medicines and Therapy Market Size by Application
  1. 6.1 Global Alternative Medicines and Therapy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Alternative Medicines and Therapy Revenue by Application (2021-2032)
  3. 6.3 Global Alternative Medicines and Therapy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Allen Laboratories Ltd.
  2. 7.1.1 Allen Laboratories Ltd. Company Information
  3. 7.1.2 Allen Laboratories Ltd. Business Overview
  4. 7.1.3 Allen Laboratories Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Allen Laboratories Ltd. Alternative Medicines and Therapy Product Portfolio
  6. 7.1.5 Allen Laboratories Ltd. Recent Developments
  7. 7.2 Arya Vaidya Pharmacy
  8. 7.2.1 Arya Vaidya Pharmacy Company Information
  9. 7.2.2 Arya Vaidya Pharmacy Business Overview
  10. 7.2.3 Arya Vaidya Pharmacy Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Arya Vaidya Pharmacy Alternative Medicines and Therapy Product Portfolio
  12. 7.2.5 Arya Vaidya Pharmacy Recent Developments
  13. 7.3 Dr. Reddy’s Laboratories Ltd
  14. 7.3.1 Dr. Reddy’s Laboratories Ltd Company Information
  15. 7.3.2 Dr. Reddy’s Laboratories Ltd Business Overview
  16. 7.3.3 Dr. Reddy’s Laboratories Ltd Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Dr. Reddy’s Laboratories Ltd Alternative Medicines and Therapy Product Portfolio
  18. 7.3.5 Dr. Reddy’s Laboratories Ltd Recent Developments
  19. 7.4 King Bio Pharmaceuticals
  20. 7.4.1 King Bio Pharmaceuticals Company Information
  21. 7.4.2 King Bio Pharmaceuticals Business Overview
  22. 7.4.3 King Bio Pharmaceuticals Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 King Bio Pharmaceuticals Alternative Medicines and Therapy Product Portfolio
  24. 7.4.5 King Bio Pharmaceuticals Recent Developments
  25. 7.5 Mediral International
  26. 7.5.1 Mediral International Company Information
  27. 7.5.2 Mediral International Business Overview
  28. 7.5.3 Mediral International Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Mediral International Alternative Medicines and Therapy Product Portfolio
  30. 7.5.5 Mediral International Recent Developments
  31. 7.6 Sandoz International GmbH, Biocon Ltd.
  32. 7.6.1 Sandoz International GmbH, Biocon Ltd. Company Information
  33. 7.6.2 Sandoz International GmbH, Biocon Ltd. Business Overview
  34. 7.6.3 Sandoz International GmbH, Biocon Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sandoz International GmbH, Biocon Ltd. Alternative Medicines and Therapy Product Portfolio
  36. 7.6.5 Sandoz International GmbH, Biocon Ltd. Recent Developments
  37. 7.7 Sante Verte Ltd.
  38. 7.7.1 Sante Verte Ltd. Company Information
  39. 7.7.2 Sante Verte Ltd. Business Overview
  40. 7.7.3 Sante Verte Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sante Verte Ltd. Alternative Medicines and Therapy Product Portfolio
  42. 7.7.5 Sante Verte Ltd. Recent Developments
  43. 7.8 Weleda Ltd., Cipla Ltd.
  44. 7.8.1 Weleda Ltd., Cipla Ltd. Company Information
  45. 7.8.2 Weleda Ltd., Cipla Ltd. Business Overview
  46. 7.8.3 Weleda Ltd., Cipla Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Weleda Ltd., Cipla Ltd. Alternative Medicines and Therapy Product Portfolio
  48. 7.8.5 Weleda Ltd., Cipla Ltd. Recent Developments
  49. 7.9 Wright Health Group Ltd.
  50. 7.9.1 Wright Health Group Ltd. Company Information
  51. 7.9.2 Wright Health Group Ltd. Business Overview
  52. 7.9.3 Wright Health Group Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Wright Health Group Ltd. Alternative Medicines and Therapy Product Portfolio
  54. 7.9.5 Wright Health Group Ltd. Recent Developments
8 North America
  1. 8.1 North America Alternative Medicines and Therapy Revenue (2021-2032)
  2. 8.2 North America Alternative Medicines and Therapy Revenue by Type (2021-2032)
  3. 8.2.1 North America Alternative Medicines and Therapy Revenue by Type (2021-2026)
  4. 8.2.2 North America Alternative Medicines and Therapy Revenue by Type (2027-2032)
  5. 8.3 North America Alternative Medicines and Therapy Revenue Share by Type (2021-2032)
  6. 8.4 North America Alternative Medicines and Therapy Revenue by Application (2021-2032)
  7. 8.4.1 North America Alternative Medicines and Therapy Revenue by Application (2021-2026)
  8. 8.4.2 North America Alternative Medicines and Therapy Revenue by Application (2027-2032)
  9. 8.5 North America Alternative Medicines and Therapy Revenue Share by Application (2021-2032)
  10. 8.6 North America Alternative Medicines and Therapy Revenue by Country
  11. 8.6.1 North America Alternative Medicines and Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Alternative Medicines and Therapy Revenue by Country (2021-2026)
  13. 8.6.3 North America Alternative Medicines and Therapy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Alternative Medicines and Therapy Revenue (2021-2032)
  2. 9.2 Europe Alternative Medicines and Therapy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Alternative Medicines and Therapy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Alternative Medicines and Therapy Revenue by Type (2027-2032)
  5. 9.3 Europe Alternative Medicines and Therapy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Alternative Medicines and Therapy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Alternative Medicines and Therapy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Alternative Medicines and Therapy Revenue by Application (2027-2032)
  9. 9.5 Europe Alternative Medicines and Therapy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Alternative Medicines and Therapy Revenue by Country
  11. 9.6.1 Europe Alternative Medicines and Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Alternative Medicines and Therapy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Alternative Medicines and Therapy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Alternative Medicines and Therapy Revenue (2021-2032)
  2. 10.2 China Alternative Medicines and Therapy Revenue by Type (2021-2032)
  3. 10.2.1 China Alternative Medicines and Therapy Revenue by Type (2021-2026)
  4. 10.2.2 China Alternative Medicines and Therapy Revenue by Type (2027-2032)
  5. 10.3 China Alternative Medicines and Therapy Revenue Share by Type (2021-2032)
  6. 10.4 China Alternative Medicines and Therapy Revenue by Application (2021-2032)
  7. 10.4.1 China Alternative Medicines and Therapy Revenue by Application (2021-2026)
  8. 10.4.2 China Alternative Medicines and Therapy Revenue by Application (2027-2032)
  9. 10.5 China Alternative Medicines and Therapy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Alternative Medicines and Therapy Revenue (2021-2032)
  2. 11.2 Asia Alternative Medicines and Therapy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Alternative Medicines and Therapy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Alternative Medicines and Therapy Revenue by Type (2027-2032)
  5. 11.3 Asia Alternative Medicines and Therapy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Alternative Medicines and Therapy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Alternative Medicines and Therapy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Alternative Medicines and Therapy Revenue by Application (2027-2032)
  9. 11.5 Asia Alternative Medicines and Therapy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Alternative Medicines and Therapy Revenue by Country
  11. 11.6.1 Asia Alternative Medicines and Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Alternative Medicines and Therapy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Alternative Medicines and Therapy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Alternative Medicines and Therapy Revenue (2021-2032)
  2. 12.2 SAMEA Alternative Medicines and Therapy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Alternative Medicines and Therapy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Alternative Medicines and Therapy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Alternative Medicines and Therapy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Alternative Medicines and Therapy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Alternative Medicines and Therapy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Alternative Medicines and Therapy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Alternative Medicines and Therapy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Alternative Medicines and Therapy Revenue by Country
  11. 12.6.1 SAMEA Alternative Medicines and Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Alternative Medicines and Therapy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Alternative Medicines and Therapy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research